Loading clinical trials...
Loading clinical trials...
RESILIENCE: Effect of Comprehensive Celecoxib Through Treatment for Advanced-Stage Head and Neck Cancer: A Randomized, Double-Blinded, Placebo-Controlled Trial
Conditions
Interventions
Celecoxib
Placebo
+2 more
Locations
1
United States
Huntsman Cancer Institute/University of Utah
Salt Lake City, Utah, United States
Start Date
November 27, 2019
Primary Completion Date
February 28, 2023
Completion Date
April 26, 2023
Last Updated
February 12, 2025
NCT06532279
NCT06868433
NCT06636734
NCT03010150
NCT06914999
NCT04900623
Lead Sponsor
University of Utah
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions